Topiramate Tablet
Product Images NDC 50090-3389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-3389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03
The text describes a change in the average monthly migraine period rate during a double-blind study after administering Topamax at doses of 100 and 200 milligrams per day. The result shows a statistically significant decrease in migraine periods, with a p-value of less than 0.01.*
FDA Label Image

Label Image (Lbl500903389)

FDA Label Image

Label Image (Lbl500903461)

Label Image (Lbl500903461)
Product name: obrnanaTe, with product code o6138-0. Each bottle contains 60 light orange tablets, each with a strength of 50mg of the active ingredient Stone AT 87 vecnces.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.